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Results: In this study, 221(93%) GNB were conﬁrmed ESBL
producers (range between centers, 74 to 99%) of which 94%
were nosocomial in origin. ESBL in intensive care unit (ICU)
and non-ICU patients was 86% and 98% respectively. Among
ESBLs in ICU, 13.5% were community acquired. Resistance
to LEV was 73.3% > P/T 27.3% and >AMK 12.3%. No resis-
tance to IMP and MER seen. Overall 61% were MDR. Four KS
(1.7%) isolates were resistant to ERT. PCR showed blaCTX-
M in 73%, blaTEM in 56% and blaSHV in 38%. Multiple genes
were present in 60%.
Conclusion: Prevalence of ESBL among GNB causing infec-
tions continues to be high in Indian medical centers. ERT
shows good activity equivalent to the tested Group 2 car-
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Objectives: MacConkey agar with ceftazidime (CMAC)
was used for early detection of extended spectrum beta-
lactamase(ESBL) for clinical sample received from ICU.
Methods: A total of 374 clinical samples were received
from ICU in the Dept. of Microbiology. Along with Mac-
Conkey agar and Blood agar, the samples were processed on
MacConkey agar with ceftazidime (1mg/L) for provisional
detection of ESBL isolates. Lactose -fermenting colonies on
MacConkey agar with ceftazidime(CMAC) were provisionally
detected as ESBL producing isolates. These isolates were
identiﬁed by standard methods. Presence of ESBL was deter-
mined by CLSI method (cefotaxime and ceftazidime disks
with and without clavulinic acid).
Results: 128 isolates showed growth on CMAC of which
50 were lactose fermenters. 31 isolates were identiﬁed as
E.coli and 19 as K.pneumoniae. All the 50 isolates were
identiﬁed as conﬁrmed ESBL producers.
Conclusion: Compared to phenotypic identiﬁcation of
ESBL producers, CMAC helps in early detection ESBLs which
can be very useful from treatment point of view. Since in
our hospital we have about 60% of ICU patients growing ESBL
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Background: Indiscriminate use of beta-lactam antibi-
otics has resulted in emergence of AmpC Beta-lactamases.
Considering the lack of comprehensive studies from India
the present study was undertaken to detect and character-
ize AmpC Beta-lactamases in clinical isolates of Escherichia
coli and Klebsiellaspp.
Methods: One hundred non-repeat clinical isolates each
of Escherichia coli and Klebsiella spp recovered from pus,
urine, blood and sputum, were collected from various hos-
pitals of Delhi. These were screened for susceptibility to
cefoxitin (30g) by disc diffusion method. The screen pos-
itive isolates were subjected to Modiﬁed 3 Dimensional
test (M3D), AmpC disk tests 1 and 2 and Inhibitor (Boronic
acid) based detection method. AmpC positive isolates were
subjected to Polymerase chain reaction (PCR) using family
speciﬁc primers and also tested for production of ESBLs and
inducible AmpC Beta-lactamases.
Results: 34/100 (34%) of Escherichia coli and 21/100
(21%) of Klebsiella spp. were resistant to cefoxitin. Of the
screen positive isolates 12 (35%) of Escherichia coli, and 5
(24%) of Klebsiella spp. were positive for AmpC by various
phenotypic tests. Out of the AmpC positive isolates as many
as 8/12 of Escherichia coli and 3/5 of Klebsiella isolates
were positive for ESBLs. In 3/12 (25%) of Escherichia coli
and 3/5 (60%) of Klebsiella isolates AmpC were inducible.
PCR identiﬁed the AmpC of Escherichia coli as MIR/ACT-
I and CIT types. Amongst Klebsiella isolates, the AmpC
were found to be of MIR/ACTI, CIT, FOX and DHA fami-
lies.
Conclusion: The incidence of AmpC production was
higher (12%) in Escherichia coli than in Klebsiella (5%) iso-
lates. However, co-production of ESBLs was much higher in
Klebsiella (60%) than in Escherichia coli (25%) isolates. The
AmpC Beta-lactamases in Indian isolates were of common
families reported from different parts of the world.
doi:10.1016/j.ijid.2008.05.281
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Pooled Analysis of Resistance Patterns of Escherichia coli
Strains Isolated From Urine Cultures in Turkey: Compari-
son of 1997—2001 and 2002—2007 Periods
M. Tasbakan, H. Pullukcu, O.R. Sipahi, T. Yamazhan, B.
Arda, S. Ulusoy ∗
Ege University Faculty of Medicine, Izmir, Turkey
Objectives: Urinary tract infections (UTI) are one of the
most common infectious diseases diagnosed in outpatients
and also constitutes the most common nosocomial infection
in many hospitals. Escsherichia coli remains the principal
causative pathogen of UTIs both in outpatients and inpa-
tients. In this study it was aimed to compare the resistance
patterns of E. coli strains reported to be isolated from urine
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cultures in published medical literature from Turkey in the
1997—2001 and 2002-September 2007 periods.
Method: To ﬁnd out the published series three
national databases (Ulakbim Turkish Medical Liter-
ature database, http://www.turkishmedline.com,
http://medline.pleksus.com.tr) and two international
databases (Pubmed and Science Citation Index (SCI))
were searched. Keywords for national databases were
[“idrar yolu infeksiyonu” or “idrar yolu enfeksiyonu” or
“urinary tract infection” or “u¨riner sistem infeksiyonu” or
“u¨riner sistem enfeksiyonu”]. Keywords for Index Medicus
and SCI-expanded were [“urinary tract infection” and
Turkey]. Articles i)published before 1997 ii)resistance data
of outpatient and inpatient strains were not analysed
seperately iii)antibiotic susceptibility data were not given,
were excluded. All studies used Kirby-Bauer disc diffusion
test by using NCCLS/CLSI criteria for determination of
antimicrobial resistance. Resistance data of inpatient and
outpatient strains were compared by Chi-square test. A p
value less than 0.05 was considered signiﬁcant.
Results: Data for 25577 E.coli strains were obtained from
53 articles (28 articles from 1997—2001 period, 25 from
2002—2007 period). Of these starins 18106 were isolated
from outpatients whereas 7471 from inpatients. The resis-
tance rates and comparisons of 1997—2001 and 2002—2007
periods are shown in Table 1.
Conclusions: Trimethoprim sulphametoxazole resistance
is very high and it cannot be recommended in the empiri-
cal treatment any more. Nitrofurantoin may be a cheap and
reasonable option in uncomplicated UTI. Aminoglycosides
and third-generation cephalosporins may be good choices
in the treatment of complicated UTI. Carbapenems may be
conserved for extended-spectrum beta lactamase producing
strains. ESBL rate in the outpatient strains is alarming. Poli-
cies to constrain resistance such as antibiotic stewardship




OXA- and MBL-Type Enzymes Among Uncommonly Isolated
Acinetobacter Spp. in Asia-Paciﬁc Nations: Natural Reser-
voir for Resistance Determinants
R. Mendes1,∗, J. Bell 2, J. Turnidge2, M. Castanheira1, R.
Jones1
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Background: Acinetobacters (AC) other than A. bauman-
nii (ACOB) are occasionally recovered from clinical sources,
but OXA and MBL genes have rarely been reported. The aim
of this study was to identify and characterize OXA and MBL
genes in AC. Gene context of blaOXA-23 detected in A. radiore-
sistans (AR) was also evaluated.
Methods: AC recovered from patients in 10 countries in
the Asia-Paciﬁc (APAC) region were tested by broth microdi-
lution. Isolates with imipenem or meropenem MIC ≥8mg/L
were screened for MBL- (IMP-like, VIM-like, SIM-1, GIM-1,
SPM-1) and OXA- (OXA-23, -24, -58 clusters) genes. OXA
genes and surrounding sequences were assessed by PCR
using primers targeting to ISAba1, 2 or 3, or degenerate
primer approach. Southern blot and hybridization of chro-
mosomal and plasmid DNA were performed. RNA extraction
followed by reverse transcriptase-PCR was performed to
access expression of blaOXA-23. Species identiﬁcation was
conﬁrmed by 16S rRNA.
Results: Among 543 AC isolates, 28.2% carried OXA
(98.7%) or MBL (1.3%) genes, from which 2.6% were found
ACOB. An A. junii (AJ) with blaOXA-23 and an AR with blaOXA-23
and blaOXA-58 were detected in 2 Indian centers, while an
A. johnsonnii with blaIMP-4 and A. calcoaceticus (ACA) with
blaOXA-58 were identiﬁed in the Philippines and China, respec-
tively. ISAba1 and ISAba3 surrounded blaOXA-23 from AJ and
blaOXA-58 from AR and ACA, respectively. The AR showed a
putative O-sialoglycoprotein endopeptidase-encoding gene
upstream of blaOXA-23; gene expression was not detected;
and blaOXA-23 and blaOXA-58 were located on the chromosome
and plasmid, respectively. Susceptibility to polymyxin and
tigecycline (≤2mg/L; no breakpoint criteria) was ≥98.9%.
Conclusion: High dissemination of OXA genes was
detected, emphasizing their ability to spread among AC.
The data suggest AR may be a natural reservoir for blaOXA-23.
blaIMP-4 has been previously detected in Hong Kong, Australia
and now Philippines, highlighting spread in APAC.
doi:10.1016/j.ijid.2008.05.283
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Mutation in DNA Gyrase and Topoisomerase IV of
V. cholerae Causing Diminished Susceptibility to
Ciproﬂoxacin
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Background: Diminishing clinical response to
ciproﬂoxacin (CIP) therapy at ICDDR, B correlated with
decreased minimum inhibitory concentration (MIC) of
V. cholerae to CIP, though strains remained susceptible
using standard thresholds. To determine the cause of the
diminished susceptibility, we investigated mutations in the
quinolone-resistance-determining-region/analogous region
of genes gyrA/B and parC/E that encode, respectively,
quinolone targets DNA gyrase and topoisomerase IV.
Method: We studied 30 clinical isolates of V. cholerae O1
and 10 of V. cholerae O139 isolated during 1993—2006. Sus-
ceptibility was determined by standard disk diffusion (DD)
and E-test methods and interpreted according to CLSI and
manufacturer’s instruction respectively. We extracted chro-
mosomal DNA, ampliﬁed and sequenced the gene fragments
and then edited, matched and aligned the sequences using
suitable methods and software to identify mutations.
Results: No mutation was detected in 9 strains having a
CIP MIC of 0.002—0.003 and a NA MIC of 0.125—0.5g/ml; a
substitution (Asparticacid87Asparagine) was noted in gyrA
was noted in 2 strains with a CIP MIC of 0.008—0.012
and a NA MIC of 4—8g/ml; a unique gyrA mutation in
